Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapyGillian Dean, Anton Pozniak, Simon Edwards et al.|AIDS|2002Cited by 359
Effect of tuberculosis therapy on nevirapine trough plasma concentrationsGillian Dean, Annemiek de Ruiter, David Back|AIDS|1999Cited by 30
Recommendations for defining preventable HIV-related mortality for public health monitoring in the era of Getting to Zero: an expert consensusSara Croxford, Ann Sullivan, Simon Collins et al.|The Lancet HIV|2023Cited by 11
P30 Use of non‐nucleoside reverse transcriptase inhibitors (NNRTI) in the treatment of HIV and mycobacterial tuberculosis (MTB) infectionLesley Navaratne, Annemiek de Ruiter, Gillian Dean et al.|HIV Medicine|2000Cited by 1
An audit of the use of prophylaxis against toxoplasmic encephalitis in HIV diseaseEmma Fox, Annemiek de Ruiter, Gillian Dean|International Journal of STD & AIDS|1998Cited by 0